FR2915385B1 - Utilisation d'un principe actif issu de l'amarante (amaranthus) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs. - Google Patents

Utilisation d'un principe actif issu de l'amarante (amaranthus) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.

Info

Publication number
FR2915385B1
FR2915385B1 FR0703062A FR0703062A FR2915385B1 FR 2915385 B1 FR2915385 B1 FR 2915385B1 FR 0703062 A FR0703062 A FR 0703062A FR 0703062 A FR0703062 A FR 0703062A FR 2915385 B1 FR2915385 B1 FR 2915385B1
Authority
FR
France
Prior art keywords
amarante
amaranthus
protecting
skin
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0703062A
Other languages
English (en)
Other versions
FR2915385A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Jean Marie Botto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Vincience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vincience SA filed Critical Vincience SA
Priority to FR0703062A priority Critical patent/FR2915385B1/fr
Priority to EP08805495A priority patent/EP2150232A2/fr
Priority to US12/597,867 priority patent/US20100137186A1/en
Priority to PCT/FR2008/000576 priority patent/WO2008145853A2/fr
Publication of FR2915385A1 publication Critical patent/FR2915385A1/fr
Application granted granted Critical
Publication of FR2915385B1 publication Critical patent/FR2915385B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0703062A 2007-04-27 2007-04-27 Utilisation d'un principe actif issu de l'amarante (amaranthus) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs. Expired - Fee Related FR2915385B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0703062A FR2915385B1 (fr) 2007-04-27 2007-04-27 Utilisation d'un principe actif issu de l'amarante (amaranthus) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
EP08805495A EP2150232A2 (fr) 2007-04-27 2008-04-23 Utlisation d'un principe actif issu de l'amarante (amaranthus) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs
US12/597,867 US20100137186A1 (en) 2007-04-27 2008-04-23 Use of an active principle originating from amaranth (amaranthus) for preparing a composition intended to activate cellular energy and to protect the skin from oxidative damage
PCT/FR2008/000576 WO2008145853A2 (fr) 2007-04-27 2008-04-23 Utlisation d'un principe actif issu de l'amarante (amaranthus) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0703062A FR2915385B1 (fr) 2007-04-27 2007-04-27 Utilisation d'un principe actif issu de l'amarante (amaranthus) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.

Publications (2)

Publication Number Publication Date
FR2915385A1 FR2915385A1 (fr) 2008-10-31
FR2915385B1 true FR2915385B1 (fr) 2012-09-28

Family

ID=38872497

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0703062A Expired - Fee Related FR2915385B1 (fr) 2007-04-27 2007-04-27 Utilisation d'un principe actif issu de l'amarante (amaranthus) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.

Country Status (4)

Country Link
US (1) US20100137186A1 (fr)
EP (1) EP2150232A2 (fr)
FR (1) FR2915385B1 (fr)
WO (1) WO2008145853A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948876B1 (fr) * 2009-08-07 2011-11-04 Oreal Association d'un rayonnement lumineux et d'un agent de nature peptidique augmentant l'expression d'un substrat de la cytochrome c oxydase pour ameliorer notamment l'apparence de la peau et/ou du cheveu
FR2958648B1 (fr) * 2010-04-09 2015-10-30 Greentech Nouveaux composes oligosaccharides et utilisation comme agent energisant
WO2011124861A2 (fr) * 2010-04-09 2011-10-13 Greentech Utilisation de composés oligosaccharides dérivés du xanthane comme agent énergisant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670635A (en) * 1993-11-29 1997-09-23 Datta; Asis Seed storage protein with nutritionally balanced amino acid composition
EP1382326A1 (fr) * 2002-07-17 2004-01-21 Cognis France S.A. Procédé pour protéger la peau contre le vieillissement
DE60336756D1 (de) * 2002-11-08 2011-05-26 Soc Extraction Principes Actif Pharmazeutische, kosmetische oder therapeutische zusammensetzungen enthaltend peptide mit dem motiv arg-gly-ser
DE10307116A1 (de) * 2003-02-19 2004-09-02 Hans Schwarzkopf & Henkel Gmbh & Co. Kg Haarbehandlungsmittel mit neuartiger Wirkstoffkombination
RU2266750C2 (ru) * 2003-07-31 2005-12-27 Одинец Алексей Глебович Способ получения биологически активной сыворотки, обогащенной пептидами
PL1799188T3 (pl) * 2004-03-12 2015-09-30 Ashland Specialties France Zastosowanie peptydów jako środka antyoksydantowego do otrzymywania kompozycji kosmetycznej i/lub farmaceutycznej
US7399491B2 (en) * 2004-12-28 2008-07-15 Council Of Scientific And Industrial Research Health promoting functional foods fortified with herbs

Also Published As

Publication number Publication date
EP2150232A2 (fr) 2010-02-10
US20100137186A1 (en) 2010-06-03
WO2008145853A3 (fr) 2009-03-05
FR2915385A1 (fr) 2008-10-31
WO2008145853A2 (fr) 2008-12-04

Similar Documents

Publication Publication Date Title
FR2915384B1 (fr) Utilisation d'un principe actif issu du soja (glycine maxl.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
FR2915383B1 (fr) Utilisation d'un principe actif issu du riz (oryza sativa l.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
IL188596A0 (en) Adipose tissue derived cells and pharmaceutical compositions containing the same
WO2010132725A3 (fr) Inhibiteurs de kinases cycline-dépendantes et leurs procédés d'utilisation
MX2013004491A (es) Boronatos como inhibidores de arginasa.
EP2108203A4 (fr) Matière active de cathode et batterie secondaire comprenant cette matière
MX2012011504A (es) Inhibidores de enzima 1 dependiente de inositol (ire-1 alfa).
CR11478A (es) Toalla para llevar puesta
MX2010009846A (es) Diaminopirimidinas como agentes fitosanitarios.
FR2898885B1 (fr) Compose a base de disphosphate de titane et de carbone, procede de preparation et utilisation comme materiau actif d'une electrode pour accumulateur au lithium.
MX2010006933A (es) Composiciones y metodos para reducir o prevenir la deshidratación de la piel.
JO2283B1 (en) Pyrimidinyl-N-Acyl-L-Phenyl Anines
UY30736A1 (es) Compuestos quimicos 537
MA32818B1 (fr) Arylpiperazines et leur emploi en tant qu'antagonistes de alpha2c
FR2953426B1 (fr) Utilisation de formulations contenant du glycerol comme agent d'aide au broyage a sec de matieres minerales.
IL192328A (en) Walls of yeast cells for the treatment and protection of plants against diseases caused by pathogenic factors and compounds containing these walls of yeast cells
FR2802772B1 (fr) Utilisation d'un complexe elicitine-lipide pour la protection des plantes contre les pathogenes
AR066814A1 (es) Nuevo humectante y su utilizacion
MY162041A (en) Imaging probes
FR2915385B1 (fr) Utilisation d'un principe actif issu de l'amarante (amaranthus) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
MY146444A (en) Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases
TW200716653A (en) Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases
MA33693B1 (fr) Dérivés de pyrazole qui modulent la stéroyl-coa désaturase
FR2887447B1 (fr) Utilisation d'un peptide comme principe actif amincissant
MY146803A (en) Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20151231